EZH2 contributes to the response to PARP inhibitors through its PARP-mediated poly-ADP ribosylation in breast cancer.

2018

EZH2 contributes to the response to PARP inhibitors through its PARP-mediated poly-ADP ribosylation in breast cancer

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

66

References

52

Citations